Home
Giới thiệu
Tài khoản
Đăng nhập
Quên mật khẩu
Đổi mật khẩu
Đăng ký tạo tài khoản
Liệt kê
Công trình khoa học
Bài báo trong nước
Bài báo quốc tế
Sách và giáo trình
Thống kê
Công trình khoa học
Bài báo khoa học
Sách và giáo trình
Giáo sư
Phó giáo sư
Tiến sĩ
Thạc sĩ
Lĩnh vực nghiên cứu
Tìm kiếm
Cá nhân
Nội dung
Góp ý
Hiệu chỉnh lý lịch
Thông tin chung
English
Đề tài NC khoa học
Bài báo, báo cáo khoa học
Hướng dẫn Sau đại học
Sách và giáo trình
Các học phần và môn giảng dạy
Giải thưởng khoa học, Phát minh, sáng chế
Khen thưởng
Thông tin khác
Tài liệu tham khảo
Hiệu chỉnh
Số người truy cập: 107,165,754
Enhancing the Physiochemical Properties of Puerarin via L-Proline Co-Crystallization: Synthesis, Characterization, and Dissolution Studies of Two Phases of Pharmaceutical Co-Crystals
Tác giả hoặc Nhóm tác giả:
Muhammad Inam , Lu Liu , Jian-Wei Wang , Ka-Xi Yu ,
Chi-Uyen Phan
, Jie Shen , Wen-Hua Zhang , Guping Tang , Xiurong Hu
Nơi đăng:
Int. J. Mol. Sci. (a journal of MDPI);
S
ố:
22(2);
Từ->đến trang
: 928-941;
Năm:
2021
Lĩnh vực:
Y - Dược;
Loại:
Bài báo khoa học;
Thể loại:
Quốc tế
TÓM TẮT
Puerarin (PUE) is a Chinese traditional medicine known to enhance glucose uptake into the insulin cells to downregulate the blood glucose levels in the treatment of type II diabetes. Nevertheless, the bioavailability of pristine PUE is limited due to its poor solubility and low intestinal permeability. In this work, we demonstrate that the solubility of PUE can be significantly enhanced via its co-crystallization with L-Proline (PRO). Two crystalline phases, namely, the solvate-free form [PUE][PRO] (
I
) and the solvated form [PUE]2[PRO]∙EtOH∙(H2O)2 (
II
) are isolated. These two phases are characterized by single-crystal X-ray diffraction (SCXRD), powder X-ray diffraction (PXRD), Fourier-transformed infrared (FT-IR) spectra, nuclear magnetic resonance (NMR), and thermogravimetric analysis in association with differential scanning calorimetry (TGA-DSC). The solubility and dissolution rate of both
I
and
II
in water, gastrointestinal tract at pH 1.2, and phosphate buffer at pH 6.8 indicates a nearly doubled increase as compared to the pristine PUE. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay of pristine PUE,
I
and
II
against murine colon cancer cell lines CT-26 and human kidney cell lines HEK-293 indicated that neither compound exhibits obvious cytotoxicity after 24 h. This work showcases that the readily available and biocompatible PRO can be a promising adjuvant to enhance the physicochemical properties of PUE toward orally administered drug formulation with improved pharmacokinetics.
ABSTRACT
Puerarin (PUE) is a Chinese traditional medicine known to enhance glucose uptake into the insulin cells to downregulate the blood glucose levels in the treatment of type II diabetes. Nevertheless, the bioavailability of pristine PUE is limited due to its poor solubility and low intestinal permeability. In this work, we demonstrate that the solubility of PUE can be significantly enhanced via its co-crystallization with L-Proline (PRO). Two crystalline phases, namely, the solvate-free form [PUE][PRO] (
I
) and the solvated form [PUE]2[PRO]∙EtOH∙(H2O)2 (
II
) are isolated. These two phases are characterized by single-crystal X-ray diffraction (SCXRD), powder X-ray diffraction (PXRD), Fourier-transformed infrared (FT-IR) spectra, nuclear magnetic resonance (NMR), and thermogravimetric analysis in association with differential scanning calorimetry (TGA-DSC). The solubility and dissolution rate of both
I
and
II
in water, gastrointestinal tract at pH 1.2, and phosphate buffer at pH 6.8 indicates a nearly doubled increase as compared to the pristine PUE. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay of pristine PUE,
I
and
II
against murine colon cancer cell lines CT-26 and human kidney cell lines HEK-293 indicated that neither compound exhibits obvious cytotoxicity after 24 h. This work showcases that the readily available and biocompatible PRO can be a promising adjuvant to enhance the physicochemical properties of PUE toward orally administered drug formulation with improved pharmacokinetics.
[
ijms-22-00928-v2 (1).pdf
]
© Đại học Đà Nẵng
Địa chỉ: 41 Lê Duẩn Thành phố Đà Nẵng
Điện thoại: (84) 0236 3822 041 ; Email: dhdn@ac.udn.vn